Prudential plc’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,000
Closed -$1.01M 460
2021
Q2
$1.01M Buy
+5,000
New +$931K 0.01% 366
2020
Q3
Sell
-2,500
Closed -$407K 588
2020
Q2
$407K Buy
+2,500
New +$380K ﹤0.01% 516

Other funds holding BBH

Prudential plc's BBH Position: Q3 2021 in Review

Prudential plc sold out of VanEck Biotech ETF (BBH) in Q3 2021, closing a stake of 5,000 shares — an estimated $1.01M sold.

Prudential plc first reported a position in BBH in Q2 2020 and held it in 2 quarters. The position peaked at $1.01M in Q2 2021. 118 funds tracked by Wall St. Rank hold BBH as of Q3 2021.

  • Prudential plc reported no remaining VanEck Biotech ETF position as of Q3 2021 after selling out during the quarter.
  • Prudential plc sold 5,000 VanEck Biotech ETF shares in Q3 2021, an estimated $1.01M.
  • Prudential plc first reported a position in VanEck Biotech ETF in Q2 2020 and held it in 2 quarters.
  • Prudential plc's VanEck Biotech ETF position peaked at $1.01M in Q2 2021.
  • 118 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2021.

Based on Prudential plc's 13F filing for Q3 2021, filed 10 Nov 2021.